Gain critical insights into drug safety and transporter interactions with BioDuro's validated vesicle-based assays for BSEP, MRP1, MRP2, MRP3, and MRP4. This robust in vitro platform helps identify compounds prone to drug-induced liver injury (DILI) and drug-drug interactions (DDI) early in development—enabling smarter candidate selection and reducing late-stage attrition.

Key Highlights

• Proactive De-risking: Identify transporter-mediated liabilities before they impact clinical outcomes.
• Rigorous Validation: Meet strict acceptance criteria with reliable, reproducible results.
• Accelerated Decision-Making: Streamline compound advancement with high-confidence data.

Download the full case study to discover how our platform enables safer compound selection and accelerates development toward IND.